Edoxaban Review Service W91047

Deadline:N/A

Tender information
Gwynedd
Flintshire and Wrexham
Isle of Anglesey
Wales
Conwy and Denbighshire
Type
Contract award
Procedure
Not given
Ref. number
BCU-MSP02-Edoxaban-W91047
Estimated value
£2,340
Duration
03/08/2026 - 31/01/2027
The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.

Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are. Part 1 - Edoxaban Patient Review Clinical review of the records of patients prescribed edoxaban. Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face. Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated. Provider is The Health Centre, Corwen Family, Green Lane, Corwen, LL21 0DN

Buyer
Betsi Cadwaladr University Health Board
buyer-email@mail.com
organization number
Contract award
tenderer iconCorwen Family Practicetenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf1 Jan 1970, 00:001 Bytes
Second document.pdf1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
27 Jul - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.